The global burden of melanoma: results from the Global Burden of Disease Study 2015

British Journal of Dermatology

Volumn 177, Issue 1, 2017, Pages 134-140

  Karimkhani, C ^a   Green, A C ^b,c   Nijsten, T ^d   Weinstock, M A ^e,f   Dellavalle, R P ^a,g,h   Naghavi, M ⁱ   Fitzmaurice, C ^i,j  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d ERASMUS MC CANCER INSTITUTE   (Netherlands)

^e PROVIDENCE VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f BROWN UNIVERSITY   (United States)

^g Food Science and Human Nutrition   (United States)

^h DEPARTMENT OF VETERANS AFFAIRS   (United States)

ⁱ UNIVERSITY OF WASHINGTON   (United States)

^j UNIVERSITY OF WASHINGTON   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; AUSTRALIA AND NEW ZEALAND; CANCER INCIDENCE; CANCER MORTALITY; CLINICAL ASSESSMENT; CONTROLLED STUDY; EASTERN EUROPE; EUROPE; FEMALE; GLOBAL DISEASE BURDEN; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MELANOMA; MORTALITY RATE; NORTH AMERICA; PREVALENCE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SEX DIFFERENCE; VERY ELDERLY; WESTERN EUROPE; ADOLESCENT; ADULT; AGE DISTRIBUTION; COST OF ILLNESS; DEMOGRAPHY; GLOBAL HEALTH; INCIDENCE; MORTALITY; SEX RATIO; SKIN TUMOR; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; COST OF ILLNESS; FEMALE; GLOBAL BURDEN OF DISEASE; GLOBAL HEALTH; HUMANS; INCIDENCE; MALE; MELANOMA; QUALITY-ADJUSTED LIFE YEARS; RESIDENCE CHARACTERISTICS; SEX DISTRIBUTION; SKIN NEOPLASMS; YOUNG ADULT;

EID: 85021095559     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.15510     Document Type: Article

References (31)

1. Institute for Health Metrics and Evaluation. The Global Burden of Disease: Generating Evidence, Guiding Policy. Seattle, WA: IHME, 2013.
2. GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016; 388:1545–1602.
3. Soerjomataram I, Lortet-Tieulent J, Parkin DM et al. Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet 2012; 380:1840–50.
4. Holterhues C, Hollestein LM, Nijsten T et al. Burden of disease due to cutaneous melanoma has increased in the Netherlands since 1991. Br J Dermatol 2013; 169:389–97.
5. Institute for Health Metrics and Evaluation. About GBD. Available at: http://www.healthdata.org/gbd/about (last accessed 3 November 2016).
6. GBD 2010 Country Collaboration. GBD 2010 country results: a global public good. Lancet 2013; 381:965–70.
7. Institute for Health Metrics and Evaluation. GBD Compare. Available at: http://vizhub.healthdata.org/gbd-compare/ (last accessed 21 October 2016).
8. Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Allen C et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 32 cancer groups, 1990 to 2015: a systematic analysis for the Global Burden of Disease Study. JAMA Oncol 2017; 3:524–48.
9. GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-causes mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the global burden of disease study 2015. Lancet 2016; 388:1459–544.
10. World Health Organization; International Agency for Research on Cancer. CI5 - Cancer Incidence in Five Continents. Available at: http://ci5.iarc.fr/Default.aspx (last accessed 4 January 2017).
11. Foreman KJ, Lozano R, Lopez AD, Murray CJ. Modeling causes of death: an integrated approach using CODEm. Popul Health Metr 2012; 10:1.
12. Neal RD, Cannings-John R, Hood K et al. Excision of malignant melanomas in North Wales: effect of location and surgeon on time to diagnosis and quality of excision. Fam Pract 2008; 25:221–7.
13. National Cancer Institute. SEER cancer statistics review 1975–2013. Available at: http://seer.cancer.gov/csr/1975_2013/ (last accessed 2 May 2017).
14. Salomon JA, Haagsma JA, Davis A et al. Disability weights for the Global Burden of Disease 2013 study. Lancet Glob Health 2015; 3:e712–23.
15. GBD 2015 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the global burden of disease study 2015. Lancet 2016; 388:1603–658.
16. Sinclair C, Foley P. Skin cancer prevention in Australia. Br J Dermatol 2009; 161(Suppl. 3):116–23.
17. Cicarma E, Juzeniene A, Porojnicu AC et al. Latitude gradient for melanoma incidence by anatomic site and gender in Norway 1996–2007. J Photochem Photobiol B 2010; 101:174–8.
18. Ghiasvand R, Lund E, Edvardsen K et al. Prevalence and trends of sunscreen use and sunburn among Norwegian women. Br J Dermatol 2015; 172:475–83.
19. Ghiasvand R, Rueegg CS, Weiderpass E et al. Indoor tanning and melanoma risk: long-term evidence from a prospective population-based cohort study. Am J Epidemiol 2017; 185:147–56.
20. Farage MA, Miller KW, Berardesca E, Maiback HI. Clinical implications of aging skin: cutaneous disorders in the elderly. Am J Clin Dermatol 2009; 10:73–86.
21. Swetter SM, Clarke CA, Keegan THM. Why do men have worse melanoma survival than women? Is it behavior, biology, or both? Available at: http://www.skincancer.org/publications/the-melanoma-letter/summer-2014-vol-32-no-2/men (last accessed 10 December 2016).
22. Olsen CM, Wilson LF, Green AC et al. Cancers in Australia attributable to exposure to solar ultraviolet radiation and prevented by regular sunscreen use. Aust N Z J Public Health 2016; 39:471–6.
23. Iannacone MR, Green AC. Towards skin cancer prevention and early detection: evolution of skin cancer awareness campaigns in Australia. Melanoma Manag 2014; 1:75–84.
24. El Ghissassi F, Baan R, Straif K et al. A review on human carcinogens – part D: radiation. Lancet Oncol 2009; 10:751–2.
25. Feldman B. Australia moves to ban tanning beds. Available at: https://www.theatlantic.com/international/archive/2013/10/australia-moves-ban-tanning-beds/309676/ (last accessed 23 February 2017).
26. McNoe BM, Reeder AI. ‘Out of the frying pan, but not into the fire’: quantifying commercial cosmetic tanning services in New Zealand to inform endgame regulation. N Z Med J 2016; 128:84–8.
27. Reeder AI, McNoe BM, Iosua EE. Sun protection practices in New Zealand secondary schools: a 2014 baseline study. Prev Med Rep 2016; 3:257–63.
28. Reeder AI, Jopson JA, Gray A. Primary school sun protection policies and practices 4 years after baseline—a follow-up study. Health Educ Res 2012; 27:844–56.
29. McNoe BM, Reeder AI. Adolescent sun protection at secondary school athletic sporting events - a misnomer. Aust N Z J Public Health 2016; 40:313–5.
30. Fong ZV, Tanabe KK. Comparison of melanoma guidelines in the USA, Canada, Europe, Australia and New Zealand: a critical appraisal and comprehensive review. Br J Dermatol 2014; 170:20–30.
31. Tromme I, Legrand C, Devleesschauwer B et al. Melanoma burden by melanoma stage: assessment through a disease transition model. Eur J Cancer 2016; 53:33–41.